# Cell Store

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cell-store

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.cellstorebio.com
- Latest round: Angel (Feb 29, 2024)
- Investors on record: 6

## About

Founded in 2022 and based in Beijing, China, Cell Store operates as a biotechnology company that focuses on cryopreservation solutions. It has 16 invention patents as well as 500 square meters of GMO standard pilot plant. Yuling Sun, the CEO of the company, graduated from Tsinghua University and is the head of the Sino-German cooperation program at the Institute of Chemistry, Chinese Academy of Sciences. The company cooperated with China National Gene Bank, China Academy of Chinese Medical Sciences, and other enterprises. In February 2024, Cell Store closed an angel funding. In November 2024, the firm closed a venture funding.

Cell Store's main business is cryopreservation solutions and related products. Its products include ice-controlled cryopreservation fluid products, including embryo cryopreservation, Tissue Organ Cryopreservation Fluid, Assisted Reproduction, and Car-T Cryopreservation Fluid. It also provides CRO (Contract Research Organization) business for biopharmaceutical companies.

The company’s revenue is generated by providing cryopreserved biological samples.

## Funding rounds

- Angel, Feb 29, 2024 — Y&R Capital, Ruisheng Equity Investment Fund Partnership, Beijing Guotou Chuangying Investment Management, Hangzhou Leiyu Investment Management, MiraclePlus, Gezhi Capital

## Investors

- Y&R Capital (https://capitalatlas.ai/funds/y-r-capital) — Angel
- Ruisheng Equity Investment Fund Partnership (https://capitalatlas.ai/funds/ruisheng-equity-investment-fund-partnership) — Angel
- Beijing Guotou Chuangying Investment Management — Angel
- Hangzhou Leiyu Investment Management (https://capitalatlas.ai/funds/hangzhou-leiyu-investment-management) — Angel
- MiraclePlus (https://capitalatlas.ai/funds/miracleplus) — Angel
- Gezhi Capital — Angel